Panel
Global Overview: Will Economic Growth Be Sustained?
Milken InstituteHenny Sender, Pierre Beaudoin, Liang Xinjun, Kevin Turner, Mark Weinberger, Andrew Witty
- China's middle class is projected to expand at 16% annually to become the world's largest, driving "number one" status for related industries and fueling health and happiness consumption growth of over 15% to 17% per year, even if overall GDP growth slows to 6–7% over the next decade.
- The Chinese manufacturing sector is expected to incur losses and face challenges for one to three years while reducing high leverage, and government leverage including SOE reform and aged care costs is anticipated to exceed the official 60%, making B2G business more difficult.
- Chinese household leverage is viewed as having significant growth potential compared to Western counterparts to fund consumption, while corporate outflows are characterized as healthy asset allocation for family education and tourism rather than capital flight.
- Long-term development cycles for aviation and mobility products spanning six to twenty years require investment decisions based on trends rather than short-term fluctuations, with fleet renewals essential to achieve a 50% emission reduction target by 2050 as older aircraft burn 50% more fuel.
- Drug discovery in the pharmaceutical sector requires 15 to 20-year cycle commitments, with cell and gene therapies necessitating new manufacturing technologies and a shift toward decentralized facilities near hospitals, alongside a necessary 14% return on R&D investment.
- The fourth industrial revolution is accelerating digital transformation and cloud adoption across traditional industries, with specific business models expected to expand from 1.5 million to 3–4 million units through predictive analytics, though cybersecurity threats are projected to persist and evolve continuously.
- Global productivity is expected to remain sluggish at approximately 0.5% with reduced capital expenditures for the last four years due to an "uncertainty tax," prompting increased M&A activity for cost reduction and business model recreation despite structural difficulties in some emerging markets.
- While globalization may face reverse trends due to nationalism and trade barriers, supply chains will remain inherently global for competitiveness, and emerging markets are expected to earn investment through governance improvements with half of the world's top 500 companies potentially headquartered there in 10 years.
- Fosun intends to continue investing in Western leadership brands to promote their growth in China, while China is expected to transition from a commodities-driven model and improve IPR laws despite current piracy rates, simultaneously facing aging population challenges.
- Innovation will require stronger pro-innovation signals and subsidies from the wealthiest nations, whereas human capital constraints in the US due to immigration policies may be offset by 24-hour engineering cycles leveraging talent in India and China.
- A lack of cure for Alzheimer's is expected soon due to undefined causal mechanisms, and political challenges regarding pricing and inequality may arise for big pharma unless breakthrough innovations are delivered, while banks currently struggle to fund long-term infrastructure due to capital requirements.
- Emerging markets are expected to face a "big problem" with aging populations driving future demand, and geopolitical tensions including rising nationalist sentiment in Europe and the UK are raising concerns resembling pre-war conditions, potentially hindering regional competitiveness without right infrastructure.